Literature DB >> 21199144

Campylobacter jejuni is not an important pathogen as a cause of diarrhea in US travelers to Mexico.

Nicolas A Villa1, Pablo C Okhuysen, Jose Flores-Figueroa, Zhi-Dong Jiang, Jaime Belkind-Gerson, Mercedes Paredes, Jamal A Mohamed, Parvathy Nair, Lily Carlin, Herbert L DuPont.   

Abstract

Campylobacter jejuni is an unusual cause of travelers' diarrhea acquired in Mexico, but previous studies have relied only on stool culture for diagnosis. We conducted a cohort study to determine if antibody seroconversion to C jejuni would better reflect the occurrence of infection acquired in Mexico. Serum IgG, IgA, and IgM antibodies to Campylobacter seroconverted in only 2 of 353 participants (0.6%). These data further support that C jejuni infection is an unusual cause of travelers' diarrhea in US visitors to Mexico.
© 2010 International Society of Travel Medicine.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21199144      PMCID： PMC3057522          DOI： 10.1111/j.1708-8305.2010.00469.x

Source DB:  PubMed          Journal:  J Travel Med        ISSN： 1195-1982            Impact factor:   8.490


  7 in total

1.  Incidence, etiology, and impact of diarrhea among deployed US military personnel in support of Operation Iraqi Freedom and Operation Enduring Freedom.

Authors:  Marshall R Monteville; Mark S Riddle; Usha Baht; Shannon D Putnam; Robert W Frenck; Kenneth Brooks; Manal Moustafa; Jaime Bland; John W Sanders
Journal:  Am J Trop Med Hyg       Date:  2006-10       Impact factor: 2.345

2.  Seasonal variation in etiology of travelers' diarrhea. Finnish-Moroccan Study Group.

Authors:  L Mattila; A Siitonen; H Kyrönseppä; I Simula; P Oksanen; M Stenvik; P Salo; H Peltola
Journal:  J Infect Dis       Date:  1992-02       Impact factor: 5.226

Review 3.  Systematic review: the epidemiology and clinical features of travellers' diarrhoea.

Authors:  H L DuPont
Journal:  Aliment Pharmacol Ther       Date:  2009-04-21       Impact factor: 8.171

4.  Incidence, etiology, and impact of diarrhea among long-term travelers (US military and similar populations): a systematic review.

Authors:  Mark S Riddle; John W Sanders; Shannon D Putnam; David R Tribble
Journal:  Am J Trop Med Hyg       Date:  2006-05       Impact factor: 2.345

5.  Treatment of travelers' diarrhea: randomized trial comparing rifaximin, rifaximin plus loperamide, and loperamide alone.

Authors:  Herbert L Dupont; Zhi-Dong Jiang; Jaime Belkind-Gerson; Pablo C Okhuysen; Charles D Ericsson; Shi Ke; David B Huang; Margaret W Dupont; Javier A Adachi; F Javier De La Cabada; David N Taylor; Sridvya Jaini; Francisco Martinez Sandoval
Journal:  Clin Gastroenterol Hepatol       Date:  2007-03-26       Impact factor: 11.382

6.  Enterotoxigenic Escherichia coli heat-labile toxin seroconversion in US travelers to Mexico.

Authors:  Jose Flores; Herbert L DuPont; Zhi-Dong Jiang; Jaime Belkind-Gerson; Jamal A Mohamed; Lily G Carlin; Ranjit S Padda; Mercedes Paredes; Jose Francisco Martinez-Sandoval; Nicolas A Villa; Pablo C Okhuysen
Journal:  J Travel Med       Date:  2008 May-Jun       Impact factor: 8.490

7.  Campylobacter jejuni as a cause of traveler's diarrhea: clinical features and antimicrobial susceptibility.

Authors:  F Gallardo; J Gascón; J Ruiz; M Corachan; M Jimenez de Anta; J Vila
Journal:  J Travel Med       Date:  1998-03       Impact factor: 8.490
  7 in total
  1 in total

Review 1.  Advances in the treatment of travelers' diarrhea.

Authors:  Mercedes Paredes-Paredes; Jose Flores-Figueroa; Herbert L Dupont
Journal:  Curr Gastroenterol Rep       Date:  2011-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.